Author: Zhongzhen Nie
Nie manages grants in the area of ion channels, GAP junctions, structural membrane lipids, integral membrane proteins, and calcium signaling. He also manages predoctoral training grants in the area of systems and integrative biology.
Posts by Zhongzhen Nie
We’re recruiting for a position in the Pharmacological and Physiological Sciences (PPS) Branch of the Division of Pharmacology, Physiology, and Biological Chemistry (PPBC). Scientific responsibilities of the position include any or all of the following research subjects, depending on the applicant’s experience: cellular signaling, drug-receptor interactions, drug metabolism and transport, drug delivery, and wound healing. The successful hire will be responsible for management of a portfolio of research grants and research training and/or career development awards, and will collaboratively stimulate, plan, advise, and direct program activities related to their field of expertise.
Continue reading “Wanted: Pharmacological and Physiological Sciences Program Director”
UPDATE: The slides [PDF] and video from this webinar are now available.
I’m pleased to announce that the Maximizing Investigators’ Research Award (MIRA) funding opportunity announcement (FOA) for established and new investigators (PAR-22-180) has been reissued. MIRA provides support for the program of research in an investigator’s laboratory that falls within the NIGMS mission. The next application due date is January 17, 2023.
We’re hosting a webinar to discuss the key features of this FOA and to answer your questions:
Friday, October 21, 12:30-2:00 p.m. ET
Zoom meeting link
Meeting ID: 160 903 8368
Passcode: NIGMS
Continue reading “Webinar for the NIGMS Maximizing Investigators’ Research Award (MIRA) Program”
We’ve issued a funding opportunity announcement (FOA) (PAR 22-180) to provide sustained support for biomedical research through our Maximizing Investigators’ Research Award (MIRA) program. This FOA allows applications from eligible NIGMS-funded investigators and from New Investigators proposing research within the scientific mission of NIGMS. The FOA also allows renewal applications from all eligible MIRA grantees (established and ex-Early Stage Investigators). Program directors (PDs)/principal investigators (PIs) who are currently Early Stage Investigators (ESIs) should apply through the ESI MIRA FOA and not to this announcement.
Continue reading “NIGMS Continues and Expands Its MIRA Program”
UPDATE: This position is now closed.
We’re recruiting for an accomplished scientist with interest and experience in sepsis, critical illness, and/or polytraumatic injury to join the Pharmacological and Physiological Sciences (PPS) Branch of the Division of Pharmacology, Physiology, and Biological Chemistry (PPBC). The successful applicant will be responsible for scientific and administrative management of a portfolio of research, career development, and training grants. Opportunities also exist for Small Business Innovation and Small Business Technology Transfer (SBIR/STTR) grants.
Continue reading “Wanted: Program Director, Pharmacological and Physiological Sciences Branch”
UPDATE: The position is now closed.
We’re recruiting for an accomplished scientist with interest and experience in total body responses to traumatic and other injuries, as well as sepsis, to join the Pharmacological and Physiological Sciences (PPS) Branch of the Division of Pharmacology, Physiology, and Biological Chemistry (PPBC). The successful applicant will have responsibility for scientific and administrative management of a portfolio of research, career development, and training grants. Opportunities also exist for Small Business Innovation and Small Business Technology Transfer (SBIR/STTR) grants.
Continue reading “Wanted: Program Director, Pharmacological and Physiological Sciences Branch”
We’ve issued a funding opportunity announcement (FOA) PAR-19-367
to maintain continued support of our Maximizing
Investigators’ Research Award (MIRA) program. Under this new FOA,
investigators with an active NIGMS R35 grant (both early-stage and established
investigator MIRA) can submit renewal MIRA applications, and investigators with
a single-PI R01-equivalent NIGMS award (DP1, DP2, R01, R37, SC1) can submit new
MIRA applications.
Continue reading “NIGMS Continues Its MIRA Program”
